Spectrum Management Group Inc. boosted its position in Clorox Co. (NYSE:CLX) by 311.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,805 shares of the company’s stock after buying an additional 2,880 shares during the period. Spectrum Management Group Inc.’s holdings in Clorox were worth $527,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in the company. Invictus RG purchased a new position in Clorox during the first quarter worth approximately $110,000. Checchi Capital Advisers LLC increased its stake in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock valued at $113,000 after buying an additional 8 shares during the last quarter. Mutual of Omaha Bank Wealth Management increased its stake in shares of Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock valued at $226,000 after buying an additional 300 shares during the last quarter. Paragon Capital Management Ltd bought a new stake in shares of Clorox during the second quarter valued at approximately $232,000. Finally, Sand Hill Global Advisors LLC increased its stake in shares of Clorox by 12.7% in the first quarter. Sand Hill Global Advisors LLC now owns 2,142 shares of the company’s stock valued at $270,000 after buying an additional 241 shares during the last quarter. Institutional investors own 70.21% of the company’s stock.
Shares of Clorox Co. (NYSE:CLX) traded down 0.61% on Friday, hitting $121.77. The stock had a trading volume of 546,589 shares. Clorox Co. has a 1-year low of $119.23 and a 1-year high of $140.47. The firm’s 50-day moving average is $125.59 and its 200 day moving average is $129.72. The stock has a market cap of $15.77 billion, a P/E ratio of 24.75 and a beta of 0.29.
Clorox (NYSE:CLX) last issued its earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The firm earned $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter last year, the firm earned $1.44 EPS. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. Equities analysts forecast that Clorox Co. will post $5.49 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be paid a $0.80 dividend. The ex-dividend date is Monday, October 24th. This represents a $3.20 dividend on an annualized basis and a yield of 2.63%. Clorox’s dividend payout ratio (DPR) is currently 64.91%.
Several equities research analysts recently commented on the company. Goldman Sachs Group Inc. reiterated a “neutral” rating and set a $131.00 target price (up from $125.00) on shares of Clorox in a report on Friday, July 15th. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a report on Tuesday, July 12th. B. Riley reiterated a “neutral” rating and set a $109.00 target price on shares of Clorox in a report on Thursday, August 4th. Citigroup Inc. raised their target price on Clorox from $134.00 to $144.00 and gave the company a “neutral” rating in a report on Monday, August 8th. Finally, Atlantic Securities upgraded Clorox from a “hold” rating to a “buy” rating and set a $144.00 target price on the stock in a report on Friday, September 16th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Clorox currently has a consensus rating of “Hold” and an average price target of $127.80.
In other news, COO Dawn C. Willoughby sold 10,617 shares of the company’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $131.01, for a total transaction of $1,390,933.17. Following the completion of the sale, the chief operating officer now owns 20,353 shares in the company, valued at approximately $2,666,446.53. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $133.07, for a total value of $123,089.75. The disclosure for this sale can be found here. 0.74% of the stock is owned by company insiders.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.